Company Filing History:
Years Active: 2005
Title: Reina Natero: Innovator in Cholesterol Management
Introduction
Reina Natero is a prominent inventor based in Menlo Park, CA (US). She has made significant contributions to the field of medical science, particularly in the area of cholesterol management. Her innovative work focuses on enhancing the expression of the ABCA-1 gene, which plays a crucial role in cholesterol efflux.
Latest Patents
Reina holds a patent for her invention titled "ABCA-1 elevating compounds." This patent describes compounds that elevate cellular expression of the ABCA-1 gene, promoting cholesterol efflux from cells and increasing HDL levels in the plasma of mammals, especially humans. The compounds are particularly useful for treating coronary artery disease. She has 1 patent to her name.
Career Highlights
Reina Natero is associated with Cv Therapeutics, Inc., where she applies her expertise in developing innovative solutions for cardiovascular health. Her work has the potential to significantly impact the treatment of coronary artery disease, making her a valuable asset in the medical research community.
Collaborations
Throughout her career, Reina has collaborated with notable professionals in her field, including Prabha N Ibrahim and Michael G Campbell. These collaborations have further enriched her research and contributed to the advancement of her inventions.
Conclusion
Reina Natero is a trailblazer in the field of cholesterol management, with her innovative compounds offering promising solutions for coronary artery disease. Her contributions to medical science are noteworthy and continue to inspire advancements in healthcare.